Department of Justice ADA Title III Regulation 28 CFR Part 36 (1991)
The ADA Home Page provides access to Americans with Disabilities Act (ADA) regulations for businesses and State and local governments, technical assistance materials, ADA Standards for Accessible Design, links to Federal agencies with ADA responsibilities and information, updates on new ADA requirements, streaming video, information about Department of Justice ADA settlement agreements, consent decrees, and enforcement activities and access to Freedom of Information Act (FOIA) ADA material
The U.S. Access Board is a federal agency that promotes equality for people with disabilities through leadership in accessible design and the development of accessibility guidelines and standards for the built environment, transportation, communication, medical diagnostic equipment, and information technology.
(PDF) Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: Implications for NeuroAIDS therapeutics | JoEllyn McMillan - Academia.edu
Academia.edu is a platform for academics to share research papers.
"The Role of Human Dopamine Transporter in NeuroAIDS" by Jun Zhu, Subramaniam Ananthan et al.
HIV-associated neurocognitive disorder (HAND) remains highly prevalent in HIV infected individuals and represents a special group of neuropathological disorders, which are associated with HIV-1 viral proteins, such as transactivator of transcription (Tat) protein. Cocaine abuse increases the incidence of HAND and exacerbates its severity by enhancing viral replication. Perturbation of dopaminergic transmission has been implicated as a risk factor of HAND. The presynaptic dopamine (DA) transporter (DAT) is essential for DA homeostasis and dopaminergic modulation of the brain function including cognition. Tat and cocaine synergistically elevate synaptic DA levels by acting directly on human DAT (hDAT), ultimately leading to dysregulation of DA transmission. Through integrated computational modeling and experimental validation, key residues have been identified in hDAT that play a critical role in Tat-induced inhibition of DAT and induce transporter conformational transitions. This review presents current information regarding neurological changes in DAT-mediated dopaminergic system associated with HIV infection, DAT-mediated adaptive responses to Tat as well as allosteric modulatory effects of novel compounds on hDAT. Understanding the molecular mechanisms by which Tat induces DAT-mediated dysregulation of DA system is of great clinical interest for identifying new targets for an early therapeutic intervention for HAND.
The nightmare of “Targeted Individuals” in an age of paranoia | The Outline
A growing number of people think they’re being tracked by unseen forces and tortured with strange devices. And increasingly, reality matches up to their worst fears.
77 FREE RISK ASSESSMENT FORMS, TEMPLATES, CHECKLISTS and APPS Top 10 Simple Things You Can Do To Dramatically Improve Safety TODAY!! You will probably not find many of these in text books or regula…
Kerberos Peripheral Rinspiration® Catheter System Featured at NY Cardiovascular Symposium
Cupertino, Calif. – Jun 27, 2006 Rinspiration Used Pre- and Post-Intervention In A Total Occlusion to Revascularize Blood Flow In 73-Year Old Patient The continued success of the Kerberos Peripheral Rinspiration® Catheter System in multi-device treatment interventions was one of … Learn more ›
Reversible On–Off Switching of Excitation-Wavelength-Dependent Emission of a Phosphorescent Soft Salt Based on Platinum(II) Complexes
Excitation-wavelength-dependent (Ex-De) emission materials show excellent potential in diverse advanced photonic areas. Of significant importance is the on-demand regulation of the Ex-De luminescence behavior of these materials, which is previously unprecedented. In this study, we report on a platinum(II) complex-based phosphorescent soft salt S1 ([Pt(tpp)(ed)]+[Pt(ftpp)(CN)2]− (where ttp = 2-(4-(trifluoromethyl)phenyl)pyridine, ed = ethane-1,2-diamine, and ftpp = 2-(4-fluoro-3-(trifluoromethyl)phenyl)pyridine)) with Ex-De photoluminescence (PL) property. UV–visible absorption and PL spectra of S1 were recorded in DMSO–H2O mixture (1 × 10–3 M) with various H2O fractions to investigate its ground and excited states. Interestingly, the PL spectra of S1 powder show that its maximum emission peak is red-shifted from 595 to 644 nm upon excitation at different wavelengths from 360 to 520 nm, accompanied by an obvious emission color change from yellow-orange to red. Furthermore, confocal laser scanning fluorescence microscopy was employed to determine the PL property of self-assembled uniform S1 nanostructure, and the result shows that the Ex-De emission behavior is absent. On the basis of these results, we conclude the various Pt(II)···Pt(II) distances that exist are the major factor responsible for the properties of the Ex-De PL of S1 powder. Thus, for the first time, reversible on–off switching of Ex-De PL of S1 was achieved by manipulating its Pt(II)···Pt(II) distances through mechanical stress and vapor fuming. Finally, we demonstrate the high-level anticounterfeiting applications via on-demand multicolor displays.
Comparative efficacy of 12 non-drug interventions on non-specific chronic low back pain in nurses: A systematic review and network meta-analysis - PubMed
Low back exercise plus health education may be the best approach to reduce NSCLBP in nurses. Considering the heterogeneity, our findings need to be confirmed in future multicenter large sample RCTs in different countries.
A nomogram based on a patient-reported outcomes measure: predicting the risk of readmission for patients with chronic heart failure - PubMed
This model offers a platform to assess the risk of readmission for different populations with CHF and can assist clinicians with personalized treatment recommendations.
History-indicated cerclage: the association between previous preterm history and cerclage outcome - PubMed
Comparison of HIC in one previous second-trimester pregnancy loss group with HIC in the 2 or more previous second-trimester pregnancy loss group found no difference in pregnancy outcome. This finding supports the amended ACOG guideline for HIC indications. Based on our results, we also propose devel …
Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS - PubMed
Drug abuse (e.g., methamphetamine-Meth or cocaine-Coc) is one of the major risk factors for becoming infected with HIV-1, and studies show that in combination, drug abuse and HIV-1 lead to significantly greater damage to CNS. To overcome these issues, we have developed a novel nanoformulation (NF) f …